• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

依折麦布可抑制膳食中氧化胆固醇掺入脂蛋白。

Ezetimibe inhibits the incorporation of dietary oxidized cholesterol into lipoproteins.

作者信息

Staprans Ilona, Pan Xian-Mang, Rapp Joseph H, Moser Arthur H, Feingold Kenneth R

机构信息

Department of Veterans Affairs Medical Center, University of California, San Francisco, CA, USA.

出版信息

J Lipid Res. 2006 Nov;47(11):2575-80. doi: 10.1194/jlr.M600261-JLR200. Epub 2006 Aug 7.

DOI:10.1194/jlr.M600261-JLR200
PMID:16894239
Abstract

Oxidized cholesterol is present in significant quantities in the typical Western diet. When ingested, oxidized cholesterol is absorbed by the small intestine and incorporated into both chylomicrons and LDL, resulting in LDL that is more susceptible to further oxidation. Feeding studies in animal models and epidemiological studies in humans have suggested that oxidized cholesterol in the diet increases the development of atherosclerosis. In this study, we determined the effect of ezetimibe, a drug that inhibits small intestinal absorption of cholesterol, on the levels of oxidized cholesterol in the serum after a test meal containing oxidized cholesterol. We demonstrate that ezetimibe, 10 mg per day for 1 month, markedly reduced the levels (50% decrease) of oxidized cholesterol in the serum after feeding a test meal containing either alpha-epoxy cholesterol or 7-keto cholesterol, two of the predominant oxidized cholesterols found in the diet. Moreover, the decrease in oxidized cholesterol in the serum was attributable to a decrease in the incorporation of dietary oxidized cholesterol into both chylomicrons and LDL. Because there was no decrease in postprandial triglyceride levels, we conclude that this decrease in oxidized cholesterol levels in the serum is attributable to decreased absorption and not to enhanced clearance. Whether this decrease in oxidized cholesterol absorption prevents or delays the development of atherosclerosis remains to be determined.

摘要

氧化型胆固醇在典型的西方饮食中大量存在。摄入后,氧化型胆固醇被小肠吸收并整合到乳糜微粒和低密度脂蛋白(LDL)中,导致LDL更容易进一步氧化。动物模型的喂养研究和人类的流行病学研究表明,饮食中的氧化型胆固醇会增加动脉粥样硬化的发生。在本研究中,我们测定了依泽替米贝(一种抑制小肠胆固醇吸收的药物)对含氧化型胆固醇的试验餐后血清中氧化型胆固醇水平的影响。我们证明,每天服用10毫克依泽替米贝,持续1个月,在喂食含有α-环氧胆固醇或7-酮胆固醇(饮食中发现的两种主要氧化型胆固醇)的试验餐后,血清中氧化型胆固醇水平显著降低(降低50%)。此外,血清中氧化型胆固醇的降低归因于饮食中氧化型胆固醇整合到乳糜微粒和LDL中的减少。由于餐后甘油三酯水平没有降低,我们得出结论,血清中氧化型胆固醇水平的降低归因于吸收减少而非清除增强。这种氧化型胆固醇吸收的减少是否能预防或延缓动脉粥样硬化的发生还有待确定。

相似文献

1
Ezetimibe inhibits the incorporation of dietary oxidized cholesterol into lipoproteins.依折麦布可抑制膳食中氧化胆固醇掺入脂蛋白。
J Lipid Res. 2006 Nov;47(11):2575-80. doi: 10.1194/jlr.M600261-JLR200. Epub 2006 Aug 7.
2
Dietary cholesterol, cholesterol absorption, postprandial lipemia and atherosclerosis.膳食胆固醇、胆固醇吸收、餐后血脂异常与动脉粥样硬化。
Can J Clin Pharmacol. 2003 Winter;10 Suppl A:26A-32A.
3
The cholesterol absorption inhibitor, ezetimibe, decreases diet-induced hypercholesterolemia in monkeys.胆固醇吸收抑制剂依泽替米贝可降低猴子因饮食引起的高胆固醇血症。
Eur J Pharmacol. 2001 Mar 9;415(1):79-84. doi: 10.1016/s0014-2999(01)00825-1.
4
The role of dietary oxidized cholesterol and oxidized fatty acids in the development of atherosclerosis.膳食氧化胆固醇和氧化脂肪酸在动脉粥样硬化发展中的作用。
Mol Nutr Food Res. 2005 Nov;49(11):1075-82. doi: 10.1002/mnfr.200500063.
5
The lipid-lowering effect of ezetimibe in pure vegetarians.依折麦布在纯素食者中的降脂作用。
J Lipid Res. 2006 Dec;47(12):2820-4. doi: 10.1194/jlr.P600009-JLR200. Epub 2006 Sep 11.
6
Ezetimibe beneficially influences fasting and postprandial triglyceride-rich lipoproteins in type 2 diabetes.依折麦布可有益改善 2 型糖尿病患者空腹和餐后富含甘油三酯的脂蛋白。
Atherosclerosis. 2011 Jul;217(1):142-8. doi: 10.1016/j.atherosclerosis.2011.03.012. Epub 2011 Mar 15.
7
Ezetimibe, a potent cholesterol absorption inhibitor, inhibits the development of atherosclerosis in ApoE knockout mice.依折麦布是一种强效的胆固醇吸收抑制剂,可抑制载脂蛋白E基因敲除小鼠动脉粥样硬化的发展。
Arterioscler Thromb Vasc Biol. 2001 Dec;21(12):2032-8. doi: 10.1161/hq1201.100260.
8
Effect of dietary cholesterol oxidation products on the plasma clearance of chylomicrons in the rat.膳食胆固醇氧化产物对大鼠乳糜微粒血浆清除率的影响。
Lipids. 2002 May;37(5):455-62. doi: 10.1007/s11745-002-0917-z.
9
Ezetimibe improves postprandial hyperlipidaemia in patients with type IIb hyperlipidaemia.依折麦布可改善IIb型高脂血症患者的餐后高脂血症。
Eur J Clin Invest. 2009 Aug;39(8):689-98. doi: 10.1111/j.1365-2362.2009.02163.x. Epub 2009 May 27.
10
Molecular mechanisms of ezetimibe-induced attenuation of postprandial hypertriglyceridemia.依泽替米贝引起的餐后高甘油三酯血症减弱的分子机制。
J Atheroscler Thromb. 2010 Sep 30;17(9):914-24. doi: 10.5551/jat.4929. Epub 2010 Jun 11.

引用本文的文献

1
Association between Serum Oxysterols and Coronary Plaque Regression during Lipid-Lowering Therapy with Statin and Ezetimibe: Insights from the CuVIC Trial.载脂蛋白 C-III 基因多态性与冠心病风险及他汀类药物降脂疗效的相关性
J Atheroscler Thromb. 2023 Aug 1;30(8):907-918. doi: 10.5551/jat.63507. Epub 2022 Dec 1.
2
Impact of combination therapy with statin and ezetimibe on secondary prevention for post-acute myocardial infarction patients in the statin era.他汀类药物与依折麦布联合治疗对他汀时代急性心肌梗死后患者二级预防的影响。
Int J Cardiol Heart Vasc. 2015 Aug 1;8:154-160. doi: 10.1016/j.ijcha.2015.07.007. eCollection 2015 Sep 1.
3
Enhanced Impact of Cholesterol Absorption Marker on New Atherosclerotic Lesion Progression After Coronary Intervention During Statin Therapy.
他汀类药物治疗期间,胆固醇吸收标志物对冠状动脉介入术后新动脉粥样硬化病变进展的影响增强。
J Atheroscler Thromb. 2017 Feb 1;24(2):123-132. doi: 10.5551/jat.32615. Epub 2016 Aug 4.
4
Efficacy of combination of Ezetimibe 10 mg and rosuvastatin 2.5 mg versus rosuvastatin 5 mg monotherapy for hypercholesterolemia in patients with type 2 diabetes.依折麦布 10 毫克联合瑞舒伐他汀 2.5 毫克与瑞舒伐他汀 5 毫克单药治疗 2 型糖尿病患者高胆固醇血症的疗效。
Lipids Health Dis. 2013 Sep 22;12:137. doi: 10.1186/1476-511X-12-137.
5
Ezetimibe impairs uptake of dietary cholesterol oxidation products and reduces alterations in hepatic cholesterol metabolism and antioxidant function in rats.依折麦布会损害大鼠对膳食胆固醇氧化产物的摄取,并减少肝脏胆固醇代谢和抗氧化功能的改变。
Lipids. 2013 Jun;48(6):587-95. doi: 10.1007/s11745-013-3790-6. Epub 2013 Apr 16.
6
Ezetimibe ameliorates intestinal chylomicron overproduction and improves glucose tolerance in a diet-induced hamster model of insulin resistance.依泽替米贝可改善饮食诱导的胰岛素抵抗仓鼠模型的肠道乳糜微粒生成过多和改善葡萄糖耐量。
Am J Physiol Gastrointest Liver Physiol. 2012 May 1;302(9):G1043-52. doi: 10.1152/ajpgi.00250.2011. Epub 2012 Feb 16.
7
Ezetimibe treatment lowers indicators of oxidative stress in hypercholesterolemic subjects with high oxidative stress.依折麦布治疗可降低氧化应激水平高的高胆固醇血症患者的氧化应激指标。
Lipids. 2011 Apr;46(4):341-8. doi: 10.1007/s11745-011-3539-z. Epub 2011 Feb 26.
8
Effect of ezetimibe on hepatic fat, inflammatory markers, and apolipoprotein B-100 kinetics in insulin-resistant obese subjects on a weight loss diet.依泽替米贝对减肥饮食的胰岛素抵抗肥胖患者肝脂肪、炎症标志物和载脂蛋白 B-100 动力学的影响。
Diabetes Care. 2010 May;33(5):1134-9. doi: 10.2337/dc09-1765. Epub 2010 Feb 25.
9
Impact of ezetimibe on atherosclerosis: is the jury still out?依折麦布对动脉粥样硬化的影响:尚无定论?
Mayo Clin Proc. 2009 Apr;84(4):353-61. doi: 10.1016/S0025-6196(11)60545-4.
10
Association between glucokinase regulatory protein (GCKR) and apolipoprotein A5 (APOA5) gene polymorphisms and triacylglycerol concentrations in fasting, postprandial, and fenofibrate-treated states.葡萄糖激酶调节蛋白(GCKR)和载脂蛋白A5(APOA5)基因多态性与空腹、餐后及非诺贝特治疗状态下甘油三酯浓度之间的关联。
Am J Clin Nutr. 2009 Jan;89(1):391-9. doi: 10.3945/ajcn.2008.26363. Epub 2008 Dec 3.